Moolec Science SA Net Income

MLEC Stock   5.08  0.29  5.40%   
As of the 3rd of February, Moolec Science secures the Risk Adjusted Performance of 0.0229, downside deviation of 11.7, and Mean Deviation of 9.22. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Moolec Science SA, as well as the relationship between them.

Moolec Science Total Revenue

402.84 Million

Moolec Science's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Moolec Science's valuation are provided below:
Gross Profit
-639.5 K
Market Capitalization
3.9 M
Enterprise Value Revenue
0.7273
Revenue
7.8 M
Earnings Share
(258.69)
We have found one hundred twenty available fundamental ratios for Moolec Science, which can be analyzed and compared to other ratios and to its peers in the industry. Investors should ensure to check all of Moolec Science's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-4.1 M-4.3 M
Net Loss-100.3 M-95.3 M
Net Loss-159 M-151 M
Net Loss(297.49)(282.62)
Net Income Per E B T 0.75  0.72 
As of February 3, 2026, Net Loss is expected to decline to about (4.3 M). The current year's Net Loss is expected to grow to about (95.3 M).
  
Build AI portfolio with Moolec Stock
Analyzing Moolec Science's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Moolec Science's current valuation and future prospects.

Latest Moolec Science's Net Income Growth Pattern

Below is the plot of the Net Income of Moolec Science SA over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Moolec Science SA financial statement analysis. It represents the amount of money remaining after all of Moolec Science SA operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Moolec Science's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moolec Science's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (111.46 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Moolec Net Income Regression Statistics

Arithmetic Mean(21,814,948)
Coefficient Of Variation(185.62)
Mean Deviation31,953,334
Median(13,802)
Standard Deviation40,492,504
Sample Variance1639.6T
Range111.4M
R-Value(0.73)
Mean Square Error815.4T
R-Squared0.53
Significance0.0009
Slope(5,858,333)
Total Sum of Squares26234.3T

Moolec Net Income History

2026-95.3 M
2025-100.3 M
2024-111.5 M
2023-7.3 M
2022-51.8 M
2021-4.5 M

Other Fundumenentals of Moolec Science SA

Moolec Science Net Income component correlations

Moolec Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Moolec Science is extremely important. It helps to project a fair market value of Moolec Stock properly, considering its historical fundamentals such as Net Income. Since Moolec Science's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Moolec Science's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Moolec Science's interrelated accounts and indicators.
Will Biotechnology sector continue expanding? Could Moolec diversify its offerings? Factors like these will boost the valuation of Moolec Science. Expected growth trajectory for Moolec significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Moolec Science data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(258.69)
Revenue Per Share
2.041
Quarterly Revenue Growth
9.483
Return On Assets
(0.22)
Return On Equity
(1.75)
Investors evaluate Moolec Science SA using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Moolec Science's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Moolec Science's market price to deviate significantly from intrinsic value.
Understanding that Moolec Science's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Moolec Science represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Moolec Science's market price signifies the transaction level at which participants voluntarily complete trades.

Moolec Science 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Moolec Science's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Moolec Science.
0.00
11/05/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/03/2026
0.00
If you would invest  0.00  in Moolec Science on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Moolec Science SA or generate 0.0% return on investment in Moolec Science over 90 days. Moolec Science is related to or competes with Virax Biolabs, Elevai Labs, Galmed Pharmaceuticals, GT Biopharma, Tivic Health, Dermata Therapeutics, and XORTX Therapeutics. Moolec Science is entity of United States More

Moolec Science Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Moolec Science's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Moolec Science SA upside and downside potential and time the market with a certain degree of confidence.

Moolec Science Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Moolec Science's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Moolec Science's standard deviation. In reality, there are many statistical measures that can use Moolec Science historical prices to predict the future Moolec Science's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Moolec Science's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.255.0824.29
Details
Intrinsic
Valuation
LowRealHigh
0.254.9724.18
Details
Naive
Forecast
LowNextHigh
0.094.7223.93
Details
1 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details

Moolec Science February 3, 2026 Technical Indicators

Moolec Science SA Backtested Returns

Moolec Science appears to be dangerous, given 3 months investment horizon. Moolec Science SA has Sharpe Ratio of 0.0244, which conveys that the firm had a 0.0244 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Moolec Science, which you can use to evaluate the volatility of the firm. Please exercise Moolec Science's Risk Adjusted Performance of 0.0229, downside deviation of 11.7, and Mean Deviation of 9.22 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Moolec Science holds a performance score of 1. The company secures a Beta (Market Risk) of 3.15, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Moolec Science will likely underperform. Please check Moolec Science's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Moolec Science's current price movements will revert.

Auto-correlation

    
  -0.57  

Good reverse predictability

Moolec Science SA has good reverse predictability. Overlapping area represents the amount of predictability between Moolec Science time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Moolec Science SA price movement. The serial correlation of -0.57 indicates that roughly 57.0% of current Moolec Science price fluctuation can be explain by its past prices.
Correlation Coefficient-0.57
Spearman Rank Test-0.69
Residual Average0.0
Price Variance1.79
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Moolec Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

4.75 Million

At present, Moolec Science's Accumulated Other Comprehensive Income is projected to increase significantly based on the last few years of reporting.
Based on the recorded statements, Moolec Science SA reported net income of (111.46 Million). This is 132.66% lower than that of the Biotechnology sector and 259.13% lower than that of the Health Care industry. The net income for all United States stocks is 119.52% higher than that of the company.

Moolec Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Moolec Science's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Moolec Science could also be used in its relative valuation, which is a method of valuing Moolec Science by comparing valuation metrics of similar companies.
Moolec Science is currently under evaluation in net income category among its peers.

Moolec Science ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Moolec Science's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Moolec Science's managers, analysts, and investors.
Environmental
Governance
Social

Moolec Fundamentals

About Moolec Science Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Moolec Science SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moolec Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moolec Science SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Moolec Science SA is a strong investment it is important to analyze Moolec Science's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Moolec Science's future performance. For an informed investment choice regarding Moolec Stock, refer to the following important reports:
Check out
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Biotechnology sector continue expanding? Could Moolec diversify its offerings? Factors like these will boost the valuation of Moolec Science. Expected growth trajectory for Moolec significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Moolec Science data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(258.69)
Revenue Per Share
2.041
Quarterly Revenue Growth
9.483
Return On Assets
(0.22)
Return On Equity
(1.75)
Investors evaluate Moolec Science SA using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Moolec Science's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Moolec Science's market price to deviate significantly from intrinsic value.
Understanding that Moolec Science's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Moolec Science represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Moolec Science's market price signifies the transaction level at which participants voluntarily complete trades.